# Assiut University: Early phase 1 study in Drug-Induced Acute Liver Injury, Tuberculosis (TB) (102 participants)

**Score:** 40/100

| Field | Value |
|---|---|
| Sponsor | Assiut University |
| Sponsor type | Academic and hospital |
| Study | Silymarin Versus N-Acetylcysteine as Protective Effect Against Anti-tuberculosis Drugs Induced Liver Injury. |
| NCT ID | NCT07875322 |
| Phase | Early phase 1 |
| Status | not yet recruiting |
| Conditions | Drug-Induced Acute Liver Injury; Tuberculosis (TB) |
| Intervention types | drug |
| Target enrollment | 102 |
| Site countries | Egypt |
| Posted | 2026-10-15 |
| Planned start | 2026-10-01 |
| Event | Newly registered study |
| Event date | 2026-10-15 |

## Why this score
- 102 participants planned.
- Not yet recruiting: vendors still being chosen.

Source: ClinicalTrials.gov (U.S. National Library of Medicine) API v2 (https://clinicaltrials.gov/study/NCT07875322). Last refreshed: 2026-11-04T06:04:38.232Z.
From public ClinicalTrials.gov registrations. Sponsor and study level only: we never list investigators, contacts or participants. A registration describes a planned study and can change. Status changes are read from each study's current status, actual dates and latest posted update, not a full change history, so an update can be a correction rather than a new change. Verify on ClinicalTrials.gov.